Don't want to launch Covid vaccine under pressure, says Bharat Biotech CMD

Asserts safety and quality are important and that his firm will develop a vaccine that's affordable for all

"The current pandemic is putting pressure on the company to come out with a vaccine quickly, but we cannot rush as safety and quality are paramount," said Krishna Ella, Chairman & MD, Bharat Biotech International.

The Hyderabad-based pharma firm has completed phase-I clinical trials for its vaccine candidate against covid-19.

"There is a tremendous pressure on us to develop the vaccine. But for us, safety and quality are paramount. We don't want to kill more people with the wrong vaccine," Ella said during an interaction with members of the Chennai International Centre on 'Covid-19 Endgame Scenarios' on Saturday.